Trial Tests Atezolizumab Plus Capecitabine in Triple-Negative Breast Cancer
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative adjuvant therapies for one of...